Amcor plc financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Amcor plc files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2017	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Revenue	9,101	9,319	9,458	12,468	12,861	14,544	14,694	13,640	15,009	23,506
Cost of revenue	7,189	7,462	7,659	9,932	10,129	11,724	11,969	10,928	12,175	18,816
Gross profit	1,912	1,857	1,799	2,536	2,732	2,820	2,725	2,712	2,834	4,690
Research and development	69.1	72.7	64	97	100	96	101	106	120	170
Selling, general and administrative	850	793	999	1,385	1,292	1,284	1,086	1,093	1,205	1,931
Operating income	916	994	792	994	1,321	1,239	1,508	1,214	1,009	1,899
Interest expense	191	210	208	207	153	159	290	348	396	676
Interest income	12.2	13.1	17	22	14	24	31	38	49	66
Other non-operating income	-21.6	-74.1	3.5	16	11	11	2	3	-12	-7
Pre-tax income	716	723	604	825	1,193	1,115	1,251	907	650	1,282
Income tax	149	119	172	187	261	300	193	163	135	181
Income from continuing operations	581	587	436	624	951	815
Net income to minority interests	17	11.4	7	4	12	10	10	10	7	0
Net income	564	575	430	612	939	805	1,048	730	511	1,106
EBITDA	1,290	1,351	1,245	1,646	1,895	1,864	2,094	1,809	1,731	3,378
EPS, basic	2.45	2.48	1.82	1.91	3.01	2.65	3.54	2.53	1.60	2.39
EPS, diluted	2.40	2.47	1.81	1.91	3.00	2.64	3.52	2.52	1.60	2.38
Shares, basic (weighted)	231	232	237	321	311	303	296	1,445	1,592
Shares, diluted (weighted)	233	233	237	321	312	304	296	288	319	464
Dividend per share	2.10	2.22	2.87	2.32	2.33	2.38	2.43	2.49	2.54	2.59

Balance sheet

	FY2017	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Cash and equivalents	562	621	602	743	850	775	689	588	827	1,115
Receivables		1,379	1,864	1,616	1,864	1,935	1,875	1,846	3,426	3,639
Inventory		1,359	1,954	1,832	1,991	2,439
Other current assets		262	374	344	561	512	531	500	710	900
Total current assets		3,620	5,210	4,535	5,266	5,853	5,308	4,965	8,434	9,326
Property, plant and equipment		2,699	3,975	3,615	3,761	3,646	3,762	3,763	8,202	7,409
Lease right-of-use assets			0	525	532	560	533	567	1,116	1,039
Goodwill	2,060	2,057	5,156	5,339	5,419	5,285	5,366	5,345	11,276	12,075
Intangible assets		325	2,307	1,994	1,835	1,657	1,524	1,391	7,403	6,588
Other non-current assets		118	187	177	184	206	309	311	357	402
Total assets		9,058	17,165	16,442	17,188	17,426	17,003	16,524	37,066	37,095
Accounts payable		1,861	2,303	2,171	2,574	3,073	2,690	2,580	3,490	4,021
Accrued liabilities		269	378	477	523	471	396	399	619	694
Short-term debt		984	5.4	11	5	14	13	12	141	15
Total current liabilities		5,055	4,542	3,974	4,345	5,103	4,476	4,261	6,987	7,435
Long-term debt		2,690	5,309	6,028	6,186	6,340	6,653	6,603	13,841	13,862
Lease liabilities			0	466	462	493	463	488	910	852
Other non-current liabilities		183	241	223	371	471	481	418	754	756
Total liabilities		8,362	11,490	11,755	12,367	13,285	12,913	12,571	25,326	25,294
Total debt		3,675	5,314	11	5	14	13	12	141	13,877
Paid-in capital		784	6,008	5,480	5,092	4,431	4,021	4,019	12,226	12,255
Retained earnings		561	324	246	452	534	865	879	548	459
Treasury stock		-10.7	-16.1	-67	-29	-18	-12	-11	-6	-16
Other comprehensive income		-709	-722	-1,049	-766	-880	-862	-1,020	-1,063	-931
Shareholders' equity		627	5,609	4,626	4,764	4,082	4,026	3,881	11,728	11,790
Minority interests		68.8	65.7	61	57	59	64	72	12	11
Total equity	588	695	5,675	4,687	4,821	4,141	4,090	3,953	11,740	11,801
Total liabilities and equity		9,058	17,165	16,442	17,188	17,426	17,003	16,524	37,066	37,095

Cash flow statement

	FY2017	FY2019	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	FY2026
Net income	581	587	437	616	951	815	1,058	740	518	1,106
Depreciation and amortization	374	357	453	652	574	625	586	595	722	1,479
Stock-based compensation	26.5	21	19	34	58	63	54	32	74	83
Deferred income tax	-29.1	-73.5	73	-114	4	-33	-57	-37	-125	-96
Change in receivables	-13.2	0.7	-84	133	-189	-272	93	-43	-228	-323
Change in inventory	-48.1	-95	3	26	-112	-626	248	95	0	-329
Change in payables	138	137	120	-48	342	711	-429	-43	220	570
Cash from operations	909	871	776	1,384	1,461	1,526	1,261	1,321	1,390	2,151
Capital expenditures	-379	-365	-332	-400	-468	-527	-526	-492	-580	-922
Acquisitions	-336	0	41.9		0	0	-121	-20	-1,653	-17
Cash from investing	-632	-242	10	38	-233	-527	-309	-476	-2,102	-524
Debt issued	3,960	607	3,229	3,194	790	1,066	522	1,024	2,181	3,214
Debt repaid	-3,745	-745	-3,108	-4,225	-530	-1,243	-330	-16	-506	-2,893
Stock issued	23.8	28.1	19	1	30	114	134	0	15	6
Share buybacks		0	0	-537	-351	-601	-432	-30	0	-1
Dividends paid	-489	-527	-680	-761	-742	-732	-723	-722	-845	-1,195
Cash from financing	-223	-543	-765	-1,236	-1,179	-891	-1,025	-857	910	-1,343
Exchange rate effect	-8.1	-27.5	1	-45	58	-108	-88	-89	41	4
Net change in cash	45.8	59.3	-19	141	107	-75	-161	-101	239	288
Free cash flow	530	506	444	984	993	999	735	829	810	1,229
Interest paid	188	209	220	212	146	155	276	336	329	611
Income taxes paid	160	150	148	304	321	256	225	253	261	451

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $42.79 on September 28, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	20.0%	Gross profit / revenue.
Operating margin	8.1%	Operating income / revenue.
EBITDA margin	14.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.5%	Pre-tax income / revenue.
Net margin	4.7%	Net income / revenue.
FCF margin	5.2%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	9.2%	Cash from operations / revenue.
Effective tax rate	14.1%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	9.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.0%	Net income / average total assets.
Return on invested capital (ROIC)	9.2%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue	0.7%	Research and development expense / revenue.
SG&A / revenue	8.2%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.4%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	3.9%	Capital expenditures / revenue.
D&A / revenue	6.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	56.6%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	17.0%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	12.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	65.5%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	19.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	11.4%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	88.2%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	8.0%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	7.5%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	95.1%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	17.3%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	12.3%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	116.4%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	1.8%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	3.3%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	48.8%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-12.2%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-4.6%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	54.7%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	19.5%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	8.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	51.7%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	18.7%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	4.4%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	2.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	2.1%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	2.1%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	0.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	43.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	19.9%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	0.1%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	29.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	16.6%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	45.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	16.2%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	8.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.25x	Current assets / current liabilities.
Quick ratio	0.64x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.15x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.18x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	37.4%	Total debt / total assets.
Liabilities / assets	68.2%	Total liabilities / total assets.
Net debt	$12.76B	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.78x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	2.81x	Operating income / interest expense.
Working capital	$1.89B	Current assets - current liabilities.
Goodwill and intangibles / assets	50.3%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$6.87B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.63x	Revenue / average total assets.
Fixed asset turnover	3.01x	Revenue / average property, plant and equipment.
Receivables turnover	6.65x	Revenue / average receivables.
Days sales outstanding	55 days	365 x average receivables / revenue.
Days payables	73 days	365 x average accounts payable / cost of revenue.
FCF conversion	111.1%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	42.9%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.38	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic	$2.39	Net income per basic share, as reported (split-adjusted).
Revenue per share	$50.68	Revenue / diluted weighted shares.
FCF per share	$2.65	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4.64	Cash from operations / diluted weighted shares.
Book value per share	$25.42	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$14.82	Tangible book value / shares outstanding.
Cash per share	$2.40	(Cash + short-term investments) / shares outstanding.
Dividend per share	$2.59	Dividend declared per common share (paid, when declared is not tagged).
Payout ratio	108.0%	Dividends paid / net income, when net income is positive.
Dividends / FCF	97.2%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	0.1%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$19.78B	Share price x shares outstanding.
Enterprise value	$32.55B	Market cap + total debt - cash - short-term investments.
P/E	17.9x	Market cap / net income. Only when net income is positive.
P/S	0.84x	Market cap / revenue.
P/B	1.68x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	16.1x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	9.20x	Market cap / cash from operations, when positive.
EV/Sales	1.38x	Enterprise value / revenue.
EV/EBIT	17.1x	Enterprise value / operating income, when both are positive.
EV/EBITDA	9.63x	Enterprise value / EBITDA, when both are positive.
EV/FCF	26.5x	Enterprise value / free cash flow, when both are positive.
FCF yield	6.2%	Free cash flow / market cap.
Earnings yield	5.6%	Net income / market cap (the inverse of P/E).
Dividend yield	6.0%	Dividends paid over the period / market cap.
Shareholder yield	6.0%	(Dividends paid + share buybacks) / market cap.

What was Amcor plc's revenue in fiscal 2026?

Amcor plc reported revenue of $23.51B for fiscal 2026, 56.6% higher than the year before.

Was Amcor plc profitable in fiscal 2026?

Yes. Net income was $1.11B, a net margin of 4.7%.

How much free cash flow did Amcor plc generate in fiscal 2026?

Cash from operations of $2.15B minus capital expenditures of $922.0M left free cash flow of $1.23B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Amcor plc